PARTNERSHIPS

The Syreon Corporation (“Syreon”) was established in 1995.

Syreon was established at the University of British Columbia for the purpose of combining medical, pharmaceutical, statistical and information sciences to conduct international health care research. Syreon now provides a full suite of research services in personalized medicine, prospective clinical studies, health economics / outcomes research, and disease management support across a broad range of therapeutic areas in more than 40 countries around the world.

Syreon partners primarily with leading global pharmaceutical corporations, emerging biotechnology companies and academic networks to identify therapeutic trends, streamline new drug investigation, monitor clinical use, define economic value, and control development costs in a broad range of acute and chronic disorders in today’s competitive and challenging environment.

Syreon Research Romania (SRR) was esatblished in 2013.

The activity of the company in Romania is led by Dr. László Lorenzovici and is supported by a team of multidisciplinary specialists with extensive knowledge of the healthcare sector in Romania and other Central and Eastern European countries.

SRR carries out and coordinates a wide range of health economic analyses for acute and chronic diseases. Resource use is being monitored and data is collected from patients and healthcare providers as well as from analysts and consultants, in order to elaborate detailed and unique cost vectors for various disease indications. Also, medical outcomes are collected to measure the burden of disease, treatment consequences and cost-effectiveness of interventions.

SRR scientists have long-standing experience with the hospital and pharmaceutical industry, especially concerning developing and maintaining administrative healthcare databases.